Based on its tissue expression pattern, genomic location, and phloretin sensitivity, NHA2/SLC9B2 activity has been linked to the Na+(Li+) counter-transport activity associated with the development of essential hypertension and diabetes in humans [11,13,14,15,16]. This evidence concerns the gene SLC9B2 and essential hypertension.